老年人的代谢综合征:当功能胜过数字时
Marcio José Concepción-Zavaleta1, Eduardo Cabellos-Acuña2, Jenyfer Maria Fuentes-Mendoza1
1School of Medicine, Universidad Científica del Sur, Lima, Peru.
TouchREVIEWS in endocrinology
|November 17, 2025
概括
由于与年龄相关的变化,传统的代谢综合征标准对老年人来说不足. 建议采用以脆弱为中心的方法,整合功能状态和身体组成,以便在老年护理中更好地分层风险.
科学领域:
- 老年医学 老年医学
- 内部医学 内部医学
- 心脏病学 心脏病学
背景情况:
- 传统的代谢综合征 (MetS) 标准可能不准确地反映了老年人的健康风险.
- 与年龄相关的生理变化,包括身体组成的变化和血管硬度的增加,挑战标准的MetS值.
- "肥胖悖论"和与老年人积极控制心血管风险因素相关的风险要求重新评估当前的指导方针.
研究的目的:
- 批评老年人群中传统的MetS诊断标准的局限性.
- 倡导对老年人的MetS评估和管理采取修订后的方法,优先考虑脆弱性和功能状态.
- 为优化护理和避免过度治疗脆弱老年人的实际策略提出建议.
主要方法:
- 审查现有的关于MetS,衰老,身体组成和脆弱的文献.
- 对老年人血压,脂质和血糖控制的严格数值目标不足的分析.
- 将功能评估工具,身体组成分析 (如DXA) 和炎症标志物整合到以老年为重点的风险分层模型中.
主要成果:
- 标准的MetS标准往往不足以确定老年人真正的代谢风险.
- 血压和脂质的密集管理可能会对脆弱的个体带来更大的风险而不是益处.
- 以脆弱为中心的方法允许更个性化和适当的风险评估和治疗策略.
结论:
- 为了管理老年人的代谢健康,需要转向以脆弱为中心的方法进行范式转变.
- 整合功能状态,身体组成和炎症标志物提供了比传统的MetS标准更全面的评估.
- 个性化治疗目标和干预措施,包括皮病查和抵抗训练,对于优化老年护理和防止过度治疗至关重要.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213


